SEC Form 4 · accession 0001181431-15-001442
ACHILLION PHARMACEUTICALS INC · ACHN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Milind Deshpande
Officer — President and CEO · Director
Period of report
Jan 21, 2015
Accepted (ET)
Jan 23, 2015 · 5:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070336
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 21, 2015 | M | 100,000 | $3.02 | A | 100,000 | D | |
| Common Stock | Jan 21, 2015 | S | 100,000 | $15.00 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $3.02 | Jan 21, 2015 | M | 100,000 | D | — | Dec 17, 2023 | Common Stock | 100,000 | 300,000 | D |
Explanation of responses
- F1These options were granted on December 17, 2013 and May 23, 2014 with 25% of the shares vesting on December 17, 2014 and an additional 6.25% vesting at the end of each three-month period thereafter.
Remarks
The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by Mr. Deshpande on December 30, 2014.